Please assess the completion status of the following clinical trial:

Trial Title: Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Japanese males and non-fertile females, defined as first generation Japanese (both parents and grandparents are of Japanese origin, the subject is born in Japan and has not been living outside of Japan for more than 5 years) aged 20-45 years .~* Clinical normal physical findings~* BMI 19 - 27, weight 50 - 95 kg~Exclusion Criteria:~* History of somatic disease/condition or ongoing psychiatric disease/condition that may interfere with the objectives of the study.~* History of psychotic disorder among first-degree relatives.~* History of use of antipsychotic, antidepressant or anxiolytic drugs, prescribed as well as non-prescribed use.~* Smoking more than 7 cigarettes per week or consumption of more than 3 portion of snuff or equivalent per day within 30 days before administration of study drug.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Four different oral dose levels of a suspension containing AZD1704
- 2 (Type: PLACEBO_COMPARATOR): oral suspension

Based on this trial design, predict the completion outcome and termination type (if applicable).